The biomarker and endocrine disruptors in mammals

Journal of Reproduction and Development

Volumn 49, Issue 5, 2003, Pages 337-345

  Choi, Kyung Chul ^a   Jeung, Eui Bae ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chungbuk National University   (South Korea)

Author keywords

17 estradiol; Calbindin D9k (CaBP 9k); Endocrine disruptor; Estrogenic compound; Mammal

Indexed keywords

1,2 DIBROMO 3 CHLOROPROPANE; 4 NONYLPHENOL; 4 TERT OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN RECEPTOR; BETA ENDORPHIN; CALBINDIN; CAMPHECLOR; CATHEPSIN B; CHLORPHENOTANE; CLUSTERIN; COMPLEMENT COMPONENT C3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIELDRIN; DIETHYLSTILBESTEROL; DIOXIN; ENDOCRINE DISRUPTOR; ENDOSULFAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GENISTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; LACTOFERRIN; MUCIN 1; ORNITHINE DECARBOXYLASE; POLYCHLORINATED BIPHENYL; PROGESTERONE RECEPTOR; PROTEIN PS2; STEROID RECEPTOR; TESTOSTERONE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; VINCLOZOLIN; VITELLOGENIN; BIOLOGICAL MARKER; ESTROGEN; MESSENGER RNA; PHENOL DERIVATIVE;

ANIMAL MODEL; BIOASSAY; CALCIUM CELL LEVEL; DRUG SCREENING; ESTROGEN ACTIVITY; GLUCURONIDATION; HAMSTER; HORMONE ACTION; HUMAN; HYPOTHALAMUS; LIVER MICROSOME; NONHUMAN; NORTHERN BLOTTING; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW; SWINE; UTERUS CONTRACTION; VAGINA CANCER; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYME INDUCTION; FEMALE; GENETICS; IN VITRO STUDY; MALE; MAMMAL; METABOLISM; RAT;

ANIMALIA; CRICETINAE; MAMMALIA; SUS SCROFA;

ANIMALS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CRICETINAE; ENZYME INDUCTION; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MAMMALS; MODELS, ANIMAL; PHENOLS; RATS; RECEPTORS, ESTROGEN; RNA, MESSENGER; SUS SCROFA;

EID: 1642402385     PISSN: 09168818     EISSN: None     Source Type: Journal    
DOI: 10.1262/jrd.49.337     Document Type: Review

References (31)

1. Korach KS, Chae K, Gibson M, Curtis S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Steroids 1991; 56: 263-270.
2. Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetcke KP, Hoffmann JL, Morrow MS, Rodier DJ, Schaeffer JE, Touart LW, Zeeman MG, Patel YM. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 1998; 106 (Suppl 1): 11-56.
3. Gray LE, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foste, P, Laskey J, Reel J, Giesy J, Laws S, McLachlan J, Breslin W, Cooper R, Di Giulio R, Johnson R, Purdy R, Mihaich E, Safe S, Sonnenschein C, Welshons W, Miller R, McMaster S, Colborn T. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol 1997; 11: 719-750.
4. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 2000; 54: 154-167.
5. Jorgensen M, Vendelbo B, Skakkebaek NE, Leffers H. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ Health Perspect 2000; 108: 403-412.
6. Miller S, Kennedy D, Thomson J, Han F, Smith R, Ing N, Piedrahita J, Busbee D. A rapid and sensitive reporter gene that uses green fluorescent protein expression to detect chemicals with estrogenic activity. Toxicol Sci 2000; 55: 69-77.
7. Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 1996; 104: 1296-1300.
8. Quesada I, Fuentes E, Viso-Leon MC, Soria B, Ripoll C, Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J 2002; 16: 1671-1673.
9. Heppell SA, Denslow ND, Folmar LC, Sullivan CV. Universal assay of vitellogenin as a biomarker for environmental estrogens. Environ Health Perspect 1995; 103 (Suppl): 9-15.
10. Ren L, Marquardt MA, Lech JJ. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem Biol Interact 1997; 104: 55-64.
11. Scallet AC, Wofford M, Meredith JC, Allaben WT, Ferguson SA. Dietary exposure to genistein increases vasopressin but does not alter β-endorphin in the rat hypothalamus. Toxicol Sci 2003; 72: 296-300.
12. Shibata N, Matsumoto J, Nakada K, Yuasa A, Yokota H. Male-specific suppression of hepatic microsomal UDP-glucuronosyl transferase activities toward sex hormones in the adult male rat administered bisphenol A. Biochem J 2002; 368: 783-788.
13. Takeyoshi M, Yamasaki K, Sawaki M, Nakai M, Noda S, Takatsuki M. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicol Lett 2002; 126: 91-98.
14. An BS, Choi KC, Kang SR, Hwang WS, Jeung EB. Novel calbindin-D9k protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats. Reprod Toxicol 2003; 17: 311-319.
15. An BS, Kang SR, Shin JH, Jeung EB. Stimulation of calbindin-D9k mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol. Mol Cell Endocrinol 2002; 191: 177-186.
16. Christakos S, Gabrielides C, Rhoten WB. Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 1989; 10: 3-26.
17. Kumar R, Wieben E, Beecher SJ. The molecular cloning of the complementary deoxyribonucleic acid for bovine vitamin D-dependent calcium-binding protein: structure of the full-length protein and evidence for homologies with other calcium-binding proteins of the troponin-C superfamily of proteins. Mol Endocrinol 1989; 3: 427-432.
18. Mathieu CL, Burnett SH, Mills SE, Overpeck JG, Bruns DE, Bruns ME. Gestational changes in calbindin-D9k in rat uterus, yolk sac, and placenta: implications for maternal-fetal calcium transport and uterine muscle function. Proc Natl Acad Sci USA 1989; 86: 3433-3437.
19. L'Horset F, Blin C, Colnot S, Lambert M, Thomasset M, Perret C. Calbindin-D9k gene expression in the uterus: Study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology 1994; 134: 11-18.
20. L'Horset F, Blin C, Brehier A, Thomasset M, Perret C. Estrogen-induced calbindin-D9k gene expression in the rat uterus during the estrous cycle: Late antagonistic effect of progesterone. Endocrinology 1993; 132: 489-495.
21. Krisinger J, Setoyama T, Leung PC. Expression of calbindin-D9k in the early pregnant rat uterus: Effects of RU 486 and correlation to estrogen receptor mRNA. Mol Cell Endocrinol 1994; 102: 15-22.
22. Krisinger J, Dann JL, Currie WD, Jeung EB, Leung PC. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus. Mol Cell Endocrinol 1992; 86: 119-123.
23. Thigpen JE, Haseman JK, Saunders H, Locklear J, Caviness G, Grant M, Forsythe D. Dietary factors affecting uterine weights of immature CD-1 mice used in uterotrophic bioassays. Cancer Detect Prev 2002; 26: 381-393.
24. Nielsen M, Hoyer PE, Lemmen JG, van der Burg B, Byskov AG. Octylphenol does not mimic diethylstilbestrol-induced oestrogen receptor-α expression in the newborn mouse uterine epithelium after prenatal exposure. J Endocrinol 2000; 167: 29-37.
25. Peknicova J, Kyselova V, Buckiova D, Boubelik M. Effect of an endocrine disruptor on mammalian fertility: Application of monoclonal antibodies against sperm proteins as markers for testing sperm damage. Am J Reprod Immunol 2002; 47: 311-318.
26. Hendry WJ III, DeBrot BL, Zheng X, Branham WS, Sheehan DM. Differential activity of diethylstilbestrol versus estradiol as neonatal endocrine disruptors in the female hamster (Mesocricetus auratus) reproductive tract. Biol Reprod 1999; 61: 91-100.
27. Hendry WJ 3rd, Sheehan DM, Khan SA, May JV. Developing a laboratory animal model for perinatal endocrine disruption: the hamster chronicles. Exp Biol Med 2002; 227: 709-723.
28. Barthold JS, Kryger JV, Derusha AM, Duel BP, Jednak R, Skafar DF. Effects of an environmental endocrine disruptor on fetal development, estrogen receptor-α and epidermal growth factor receptor expression in the porcine male genital tract. J Urol 1999; 162: 864-871.
29. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002; 110: A703-707.
30. Takeuchi T, Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 2002; 291: 76-78.
31. Piasek M, Laskey JW, Kostial K, Blanusa M. Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue. Int Arch Occup Environ Health 2002; 75: S36-44.